Genentech · 2 hours ago
2026 Summer Intern - Quality Assurance Operations
Philadelphia, PA
Internship
Onsite
Intern
$23/hr - $28/hr
Start in 2026 SummerGenentech is a leading biotechnology company, and they are seeking a Summer Intern for their Quality Assurance Operations department. The intern will be responsible for developing comprehensive Value Stream Maps, preparing process maps for inspections, and creating Standard Operating Procedures to ensure compliance with regulatory requirements.
BiotechnologyLife ScienceManufacturing
Responsibilities
Develop a comprehensive Value Stream Map for activities from manufacturing through distribution for clinical and commercial product
Prepare process maps that will be utilized during health authority inspections and quality audits
Create a new Standard Operating Procedure (SOP) for the chain of custody of product, from manufacturing through shipment to clinical sites/distribution sites
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Biology, Chemistry, Engineering, or related science discipline
Solid technical writing skills
Strong analysis and problem-solving skills, including, but not limited to, the ability to review and analyze data
Strong critical thinking to analyze complex situations and discern critical issues
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-23
Genetic Engineering News
2026-01-23
Company data provided by crunchbase